Biopharmaceutical Data Strategy & Implementation

Turn data from a fire you're constantly putting out into the engine that runs your day.

Data shouldn't be a liability. I bring sanity, compliance, and readiness to your Biopharma data systems—transforming complex assets into clear advantages. Give your team the data foundation and tools they need to drive success.

LIMS QMS MES ERP Excel PDFs GOVERNANCE COMPLIANCE AI-READY
82%
of analysts' time goes to finding, preparing and governing data — under 20% to actual analysis. (IDC)
Top 5
"Investigations" and "Documentation" rank among the most-cited FDA inspection deficiencies. (FDA 2024 data, via ISPE)
100%
Inspection readiness. Excel, PDFs, and legacy systems mapped into a single audit-ready layer before the FDA knocks.
The problem

Your data isn't missing. It's scattered.

A single batch leaves a trail across LIMS, QMS, MES and ERP — plus the spreadsheets, PDFs and inboxes in between. None of it was built to talk to the rest. So when you need a coherent picture, you don't analyze. You chase: across systems, across people, across versions you're not sure you can trust.

That's why a deviation investigation takes hours before anyone reaches the actual root cause. Most of that time is spent locating, formatting and reconciling data — not reasoning about what went wrong.

It's also why inspection readiness becomes a recurring fire drill. The evidence exists; proving it's complete, attributable and contemporaneous on demand is the hard part. When the foundation is fragmented, every downstream decision inherits the doubt.

None of this is a tooling problem you can buy your way out of. It's first a strategy, governance and execution problem — getting the right data into the right shape, kept compliant, and trusted across CMC and supply chain. From there, once the foundation is set, agentic AI can be a top value-driver of efficiency, automation and a reasoning-partner for every employee. I can help you get there by providing strategy, management and implementation in both the data foundation and the AI system.

What I do

Data strategy, execution and compliance — built to last.

Data Strategy

System mapping, governance and gap analysis, turned into a roadmap that sequences the highest-value fixes first.

Data Execution

Master data management, integration and automation eliminates 'seek-and-search' data aggregation.

Regulatory Compliance

21 CFR Part 11, ALCOA+, validation support and Continued Process Verification — designed in from the start, not bolted on.

AI Strategy & Execution

For teams ready for it: agentic workflow automation on top of the connected foundation, with the adoption support to make it stick.

Where the foundation leads

Once the data is connected, the hard things get fast.

A connected, governed foundation isn't just tidy — it's what lets modern tools work. I build and validate working agentic AI demos in real CMC workflows, including a deviation investigation taken from hours to about ten minutes. The AI is the return on fixing the data — not a substitute for it.

See the working demos on LinkedIn →
~20
years of data strategy, management and implementation in regulated biopharma
Who you're working with

Kyle Langham has spent roughly two decades building and governing data systems in the biopharmaceutical industry — with leadership work spanning CMC, supply chain, IT, PMO and clinical, across business intelligence, compliance and large-scale data integration.

HGSGSKNovavax
Clinical  →  CMC  →  Supply Chain  ·  Part 11 / ALCOA+ · CPV · data quality · business intelligence
How I work

Start small, prove value, then scale.

01

Data Diagnostic

Fixed scope · fixed fee

A focused engagement that maps your data landscape, surfaces the compliance and sprawl risks, and names the single highest-ROI fix to start with. Low commitment, concrete output, and a clear view of what a trustworthy foundation would take.

02

Fractional Partnership

Ongoing · monthly retainer

Embedded, senior data leadership without a full-time hire. I execute the roadmap, build the connected foundation, and keep it compliant, at the pace your validation and change-control reality allows.

Pricing is scoped to the engagement, not pulled off a menu. The diagnostic is deliberately low-risk so you can judge the work before committing to more.

Operating outside of biopharma? The underlying architecture of connecting unstructured data to rigid, highly regulated systems of record applies equally to aerospace, defense, and advanced manufacturing. Let's connect to map your industry's specific compliance constraints.

Stop chasing your data. Start trusting it.

A 30-minute call is enough to find the first fix worth making.

Book a 30-minute call